Basilea Pharmaceutica AG Share Price
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.65 CHF | -0.09% |
|
+0.56% | -1.83% |
| Market Cap | 666M 825M 723M 618M 1.17B 78.71B 1.19B 7.97B 3.1B 38.64B 3.1B 3.03B 134B | P/E 2026 * |
14.3x | P/E 2027 * | 18.7x |
|---|---|---|---|---|---|
| Enterprise Value | 513M 636M 557M 477M 905M 60.71B 917M 6.15B 2.39B 29.8B 2.39B 2.34B 103B | EV / Sales 2026 * |
1.98x | EV / Sales 2027 * | 1.69x |
| Free-Float |
91.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Basilea Pharmaceutica AG
| 1 day | -0.09% | ||
| 1 week | +0.56% | ||
| Current month | +0.56% | ||
| 1 month | +9.59% | ||
| 3 months | +1.32% | ||
| 6 months | +0.19% | ||
| Current year | -1.83% |
| 1 week | 52.2 |  | 55.3 |
| 1 month | 47.8 | | 55.3 |
| Current year | 47.8 | | 59.2 |
| 1 year | 44.7 | | 59.7 |
| 3 years | 32 | | 59.7 |
| 5 years | 29.55 | | 59.7 |
| 10 years | 29.28 | | 95.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 18/04/2018 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 09/04/2019 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 30/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 28/11/2011 |
| Chairman | 71 | 08/04/2013 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 26/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-28 | Sell | -400 | 0.0030% | |||
| 05-12 | Sell | -1,043 | 0.0078% | |||
| 05-03 | Sell | 400 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | +0.56% | +15.36% | +32.76% | 825M | |
| 0.00% | +6.38% | +4.05% | +10.59% | 50.25B | |
| +0.40% | -1.37% | +401.69% | +625.15% | 40.39B | |
| -0.52% | +6.57% | +25.41% | -5.37% | 34.38B | |
| +3.97% | +6.71% | +26.06% | +63.36% | 34.4B | |
| -4.19% | -1.84% | +3.76% | +32.17% | 26.32B | |
| -2.40% | +1.60% | - | - | 16.64B | |
| +1.34% | +5.68% | +75.77% | +141.51% | 16.14B | |
| +1.40% | +1.66% | +15.63% | +22.84% | 13.71B | |
| +1.69% | +3.09% | +93.44% | +99.19% | 13.75B | |
| Average | +0.17% | +3.46% | +73.46% | +113.58% | 24.68B | |
| Weighted average by Cap. | +0.21% | +4.03% | +91.37% | +141.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 259M 321M 281M 240M 456M 30.59B 462M 3.1B 1.21B 15.02B 1.2B 1.18B 52.07B | 267M 332M 290M 248M 471M 31.63B 478M 3.2B 1.25B 15.53B 1.25B 1.22B 53.83B |
| Net income | 51.57M 63.93M 55.99M 47.87M 90.9M 6.1B 92.13M 617M 240M 2.99B 240M 235M 10.38B | 39.24M 48.65M 42.6M 36.42M 69.17M 4.64B 70.1M 470M 183M 2.28B 183M 179M 7.9B |
| Net Debt | -152M -189M -165M -141M -268M -18B -272M -1.82B -709M -8.84B -709M -693M -30.64B | -213M -264M -231M -197M -375M -25.14B -380M -2.54B -990M -12.34B -990M -968M -42.78B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | CHF 53.70 | 0.00% | 3,513 |
| 06/07/26 | CHF 53.70 | -1.10% | 20,507 |
| 03/07/26 | CHF 54.30 | +2.26% | 48,517 |
| 02/07/26 | CHF 53.10 | +0.38% | 19,102 |
| 01/07/26 | CHF 52.90 | -0.94% | 25,377 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSLN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
